Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

ValiRx (VAL) Share News

IN BRIEF: ValiRx subsidiary to supply cell-based assays to OncoBone

19th Jun 2023 11:51

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphaea Biolabs Ltd enters agreement with OncoBone Ltd. Says OncoBone clients will be able to access Inaphaea services. Notes Inaphaea is now confirmed as a cell-based assay supplier to OncoBone. Adds Inaphaea's services are now listed on scientist.com, a database website used by biotechnology and pharmaceutical companies. Read More

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

16th Jun 2023 10:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

ValiRx shares drop after cancer drug research dropped

16th Jun 2023 09:09

(Alliance News) - ValiRx PLC shares fell on Friday, after it ended its evaluation agreement with Hokkaido University to research a potential drug. Read More

LONDON MARKET OPEN: Stocks head higher as pound tops USD1.28 again

16th Jun 2023 08:47

(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions. Read More

ValiRx buys Imagen's scientific assets for cancer screening services

14th Jun 2023 11:35

(Alliance News) - ValiRx PLC on Wednesday said it acquired the scientific assets of Imagen Therapeutics Ltd from its appointed liquidators for GBP170,000. Read More

ValiRx expands cancer research agreement with University of Barcelona

7th Jun 2023 12:44

(Alliance News) - ValiRx PLC on Wednesday said it has expanded a pre-existing agreement with the University of Barcelona to test additional molecules as possible drugs for cancer. Read More

TRADING UPDATES: FireAngel signs with British Gas; Shanta pours gold

31st Mar 2023 16:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Ediston signs 10-year lease with Marks & Spencer

1st Mar 2023 20:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

3rd Feb 2023 13:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

26th Jan 2023 15:44

TRADING UPDATES: Future Metals in JV; Gunsynd sells stake in investee

17th Jan 2023 21:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility

13th Jan 2023 13:31

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million from placing of 9.1 million shares at 11 pence each. Also will raise up to GBP500,000 more from a broker offer to retail investors at the same price. Turner Pope Investments Ltd will run the broker offer. Every four shares in the placing and retail offer come with a warrant to buy another new share at 14p over the next three years. Calls February 2 general meeting to approve the fund raise. Currently has a GBP10.1 million market capitalisation. Read More

ValiRx shares fall on test extension, but optimistic of other assets

6th Dec 2022 11:31

(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experimental testing. Read More

ValiRx teams with King's College London for cancer project

24th Oct 2022 10:05

(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching subsidiary company Cytolytix Ltd and signing a licence agreement with King's College London. Read More

IN BRIEF: ValiRx shares up on new interim chief scientific officer

8th Sep 2022 11:47

ValiRx PLC - Nuneaton, England-based drug development company - Appoints Catherine Tralau-Stewart as interim chief scientific officer. Says she has experience working across leading pharmaceutical companies and academic groups. Tralau-Stewart will review new, incoming science; enhance the progress of existing projects; and influence the overall strategic scientific direction of the company, ValiRx adds. Chief Executive Suzy Dilly comments: "I'm looking forward to having another in-house scientist with whom to share ideas and to develop and deliver upon our strategic ambitions. Cathy's wealth of experience in exactly the areas in which we wish to progress, makes her an excellent choice for this role." Read More

EARNINGS UPDATES: Windward widens loss as operating expenses rise

31st Aug 2022 13:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

13th Jul 2022 14:44

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is "good evidence" of biological activity and a "strong" rationale for further development. Adds that the drug candidate was investigated over nine months. Tests also demonstrate promising data on ovarian cancer cells, in addition to the targeted breast cancer cells. As a result, ValiRx has notified the academic team and intellectual property & licensing team at King's College London that it wants to proceed to full in-licensing. Read More

FTSE 100 Latest

Value10,850.03

Change-12.47